Prioritizing Infectious Disease Therapies Post-COVID-19
Luc Gagnon, PhD
Infectious diseases beyond COVID-19 continue to be a growing public health concern
Luc Gagnon, PhD
Luc Gagnon, PhD, vice president of vaccine sciences, leads scientific and operations at Nexelis to support vaccines and biologics throughout the different phases of clinical trials. Luc brings more than 20 years of experience in several biotech, CRO, and pharmaceutical companies to his role, including extensive expertise in ligand binding and microbiology/virology functional assay development, qualification, and validation.